DS
CTIC

DRW Securities’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

DRW Securities’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-55,561
Closed -$277K – 118
2018
Q2 		$277K Buy
55,561
+4,000
+8% +$17.5K 0.02% 54
2018
Q1 		$201K Hold
51,561
– – 0.01% 120
2017
Q4 		$138K Buy
51,561
+35,000
+211% +$103K 0.01% 429
2017
Q3 		$53K Buy
+16,561
New +$55.3K 0.02% 59
2015
Q3 		– Sell
-25,000
Closed -$488K – 134
2015
Q2 		$488K Sell
25,000
-23,695
-49% -$457K 0.05% 69
2015
Q1 		$881K Buy
+48,695
New +$1.1M 0.14% 43

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DRW Securities's CTIC Position: Q3 2018 in Review

DRW Securities sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q3 2018, closing a stake of 55,561 shares — an estimated $277K sold.

DRW Securities first reported a position in CTIC in Q1 2015 and held it in 6 quarters. The position peaked at $881K in Q1 2015. 79 funds tracked by Wall St. Rank hold CTIC as of Q3 2018.

  • DRW Securities reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q3 2018 after selling out during the quarter.
  • DRW Securities sold 55,561 CTI BioPharma Corp. (DE) Common Stock shares in Q3 2018, an estimated $277K.
  • DRW Securities first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2015 and held it in 6 quarters.
  • DRW Securities's CTI BioPharma Corp. (DE) Common Stock position peaked at $881K in Q1 2015.
  • 79 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2018.

Based on DRW Securities's 13F filing for Q3 2018, filed 14 Nov 2018.